Purchase Order 75F40120P00355
Award Date
7/9/20
Potential Completion Date
7/12/21
Potential Value
$29K
Federal Agency
Food and Drug Administration
Awardee
Genoway
Ultimate Awardee
Not listed
NAICS Category
112990 - All Other Animal Production
PSC Category
8820 - Live Animals, Not Raised For Food
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Genoway, a global biotechnology company, to provide services related to the revitalization, shipment, and establishment of replacement embryos for the YAN1 and YAN2 mouse lines. The potential value of the contract is $22,800.00, and it has a completion date of August 9, 2022. Genoway has previously provided similar services to the DHHS FDA, including the development...
The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development awarded a $13,953 firm fixed price purchase order to Genoway, a company based in France. Under the contract, Genoway will develop a knockout targeting vector and design a screening strategy to support the NIH's research efforts from September to December 2014. No additional details were provided on the original solicitation or work scope. Genoway is the prime...
<p>This is a $4,075,691.59 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Genway Biotech, LLC, a small business. The contract is for a "PATH FIELD STUDY ANALYTES BIOMARKERS TO BE ANALYZED" requirement, with a period of performance ending on May 10, 2020. Genway Biotech, LLC is a subsidiary of Aviva Systems Biology Corporation. The contract was set aside for total small business participation.</p>
This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, with a ceiling value of $67,700.00, is for the provision of genetically modified (GM) mice and rats to support...
This is a firm fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Gempharmatech LLC, a foreign-owned for-profit biotechnology company. The contract is for the development of a conditional knockout mouse line to support NICHD's research. The total ceiling value of the contract is $14,380.00 with a completion date of January 5, 2024. There is no set-aside...
The U.S. Department of Defense's Medical Command awarded a Firm Fixed Price Purchase Order contract valued at $129,064.01 to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, identified as W81XWH16P0294, is for the MIR-188 GENE TARGETING effort, which was set aside for small businesses. The period of performance runs through October 30, 2020. Based on the information provided, Ozgene serves as the...
This is a firm fixed-price delivery order awarded by the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Ozgene Pty Ltd, an Australian company, to provide genetically modified (GM) mice and rats to support biomedical research. The contract has a ceiling value of $67,700.00 and a period of performance ending on April 27, 2011. Ozgene, as the prime contractor, will provide gene targeting vectors, mouse backcrossing, and the creation of gene...
This federal contract award to Ozgene PTY LTD, an Australian company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services. The $65,800 firm fixed-price delivery order is for the provision of genetically modified mouse strains to support biomedical research. Ozgene, the prime contractor, specializes in gene targeting, knockout, and knock-in mouse models....
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Cyagen Biosciences Inc., a self-certified small disadvantaged business. The $16,950.00 firm-fixed price purchase order is for "CYAGEN BIOSCIENCE DOUBLE KNOCKOUT MOUSE PRODUCTION" services. The contract does not have a set-aside designation and is set to conclude on September 15, 2014. Cyagen Biosciences Inc. is the prime contractor, and no major...
This federal contract award to Ozgene PTY LTD, an Australian company, is for the delivery of genetically modified mice and related services to support biomedical research at various institutes and centers within the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The specific services provided under this $5,970.00 firm fixed price delivery order contract include gene targeting vector design and creation, mouse embryonic stem cell generation, blastocyst...